See more : Rodium Realty Limited (RODIUM.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Titan Medical Inc. (TMDI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Titan Medical Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Columbia Care Inc. (CCHW.NE) Income Statement Analysis – Financial Results
- GRM Overseas Limited (GRMOVER.BO) Income Statement Analysis – Financial Results
- Argus Capital Corp. (ARGUW) Income Statement Analysis – Financial Results
- HCP PLASTENE BULKPACK LIMITED (HPBL.BO) Income Statement Analysis – Financial Results
- Integrative Health Technologies, Inc. (IHTI) Income Statement Analysis – Financial Results
Titan Medical Inc. (TMDI)
About Titan Medical Inc.
Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures. The company is headquartered in Toronto, Canada.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 20.09M | 20.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 58.06K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 20.09M | 20.00M | -58.06K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 37.96M | 7.94M | 51.42M | 32.86M | 12.90M | 22.58M | 38.21M | 10.68M | 5.35M | 4.64M | 12.48M | 1.57M | 158.77K | 1.44M | 150.91K |
| General & Administrative | 12.43M | 7.49M | 7.81M | 6.80M | 5.97M | 4.93M | 3.53M | 3.50M | 3.48M | 3.08M | 3.07M | 1.97M | 548.18K | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 140.98K | -5.00 | 2.00 | 1.00 | -5.00 | 1.00 | -4.00 | -114.22K | 9.82K | 240.83K | 134.87K | 11.76K | 0.00 | 0.00 |
| SG&A | 12.43M | 7.63M | 7.81M | 6.80M | 5.97M | 4.93M | 3.53M | 3.50M | 3.37M | 3.09M | 3.31M | 2.11M | 559.94K | 692.32K | 132.00K |
| Other Expenses | 699.00K | 0.00 | 32.55K | 29.04K | 17.36K | 24.64K | 32.39K | 23.66K | 118.75K | 155.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 51.08M | 15.57M | 59.27M | 39.69M | 18.88M | 27.53M | 41.77M | 14.20M | 8.83M | 7.88M | 15.79M | 3.68M | 718.71K | 2.13M | 282.91K |
| Cost & Expenses | 51.08M | 15.80M | 59.73M | 38.71M | 19.43M | 27.81M | 42.64M | 14.77M | 9.13M | 7.85M | 15.89M | 3.72M | 741.82K | 2.15M | 303.09K |
| Interest Income | 73.00K | 29.14K | 115.58K | 288.30K | 17.44K | 7.54K | 88.64K | 305.29K | 59.16K | 87.26K | 93.11K | 33.80K | 28.16K | 16.69K | 0.00 |
| Interest Expense | 125.00K | 1.09M | 422.99K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 165.48K | 27.57K |
| Depreciation & Amortization | 699.00K | 236.84K | 32.56K | 29.04K | 17.36K | 24.64K | 32.39K | 23.66K | 289.47K | 132.65K | 95.68K | 41.41K | 23.11K | 19.19K | 20.19K |
| EBITDA | -13.98M | -22.86M | -41.45M | -22.61M | -33.57M | -23.30M | -41.38M | -13.43M | -8.78M | -7.63M | -15.70M | -3.65M | -690.55K | -2.12M | -282.91K |
| EBITDA Ratio | -69.57% | -114.28% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -14.68M | -23.09M | -41.48M | -22.64M | -33.59M | -23.32M | -41.41M | -13.45M | -9.07M | -7.76M | -15.80M | -3.69M | -713.66K | -2.14M | -303.09K |
| Operating Income Ratio | -73.05% | -115.47% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 16.19M | -1.09M | 10.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -14.80M | -24.18M | -41.91M | -22.64M | -33.59M | -23.32M | -41.41M | -13.45M | -9.07M | -7.76M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | -73.67% | -120.92% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 56.00K | 1.09M | 422.99K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 165.48K | 27.57K |
| Net Income | -14.86M | -25.28M | -42.33M | -22.64M | -33.59M | -23.32M | -41.41M | -13.45M | -9.07M | -7.76M | -15.80M | -3.69M | -713.66K | -2.30M | -330.66K |
| Net Income Ratio | -73.95% | -126.38% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.22 | -0.38 | -1.38 | -1.36 | -4.25 | -4.77 | -11.92 | -4.29 | -3.87 | -3.63 | -8.73 | -2.58 | -0.64 | -2.94 | -8.50 |
| EPS Diluted | -0.22 | -0.38 | -1.38 | -1.36 | -4.25 | -4.77 | -11.92 | -4.29 | -3.87 | -3.63 | -8.73 | -2.58 | -0.64 | -2.94 | -8.50 |
| Weighted Avg Shares Out | 67.01M | 67.01M | 30.69M | 16.64M | 7.90M | 4.89M | 3.48M | 3.14M | 2.34M | 2.14M | 1.81M | 1.43M | 1.11M | 782.20K | 38.89K |
| Weighted Avg Shares Out (Dil) | 67.01M | 67.01M | 30.69M | 16.64M | 7.90M | 4.89M | 3.48M | 3.14M | 2.34M | 2.14M | 1.81M | 1.43M | 1.11M | 782.20K | 38.89K |
Analysts Estimate Titan Medical Inc. (TMDI) to Report a Decline in Earnings: What to Look Out for
Titan Medical Inc. (TMDI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Robotics Investments In December 2021
Robotics Investments In December 2021
Titan Medical to Participate in H.C. Wainwright BioConnect 2022 Virtual Investor Conference
TORONTO--(BUSINESS WIRE)--Titan Medical to Participate in H.C. Wainwright BioConnect 2022 Virtual Investor Conference
Titan Medical Completes Final Milestone Under Development Agreement with Medtronic
TORONTO--(BUSINESS WIRE)--Titan Medical Completes Final Milestone under Development Agreement with Medtronic
Titan Medical: Developing Single-Access Robotic Assisted Surgical Technologies
Titan Medical is developing single-access robotic assisted surgical technologies to be incorporated in its flagship Enos minimally invasive surgery system. Enos system is a mobile MIS cart integrated with a surgeon workstation. The Company intends to initially pursue gynecologic surgical...
Titan Medical Inc.'s (TMDI) CEO David McNally on Q3 2021 Results - Earnings Call Transcript
Titan Medical Inc.'s (TMDI) CEO David McNally on Q3 2021 Results - Earnings Call Transcript
Titan Medical to Report Third Quarter 2021 Financial Results on November 11, 2021
TORONTO--(BUSINESS WIRE)--Titan Medical to Report Third Quarter 2021 Financial Results on November 11, 2021
Titan Medical's (TMDI) CEO David McNally on Q2 2021 Results - Earnings Call Transcript
Titan Medical's (TMDI) CEO David McNally on Q2 2021 Results - Earnings Call Transcript
Titan Medical Reports Second Quarter 2021 Financial Results
TORONTO--(BUSINESS WIRE)--Titan Medical Announces Second Quarter 2021 Financial Results
Titan Medical Announces Appointment of Tammy Carrea as Vice President of Quality and Regulatory Affairs
TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced the appointment of Tammy Carrea as Vice President of Quality and Regulatory...
Source: https://incomestatements.info
Category: Stock Reports